TP53 and malignant colon neoplasm: A recent study by Kang et al. 2018 examined the underlying molecular mechanisms of the apoptotic effect of Luteolin mediated by the DNA methylation of the Nrf2 promoter and the interaction of Nrf2 and a well-known tumor suppressor, p53, in human colon cancer cells [48].